Clinical Trial Update: Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and immunogenicity of a DNA priming and MVA boosting HIV vaccine strategy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Instituto Nacional de Saúde, Mozambique | Conditions: HIV Infections | Phase 1 | Status: COMPLETED